SUDA Releases Preliminary Final Report for Financial Year 2019-2020

August 31, 2020 12:24 PM AEST | By Team Kalkine Media

Google News:

Recent News

ASX200 Stocks Eye Calm Rebound as Energy, Uranium Sectors Show Diverge...

Greatland Resources Set for ASX200 Exposure with Strong Demand Ahead o...

Element 25 Advances Butcherbird Expansion with A$50M NAIF Backing; Set...

Trump's G7 Exit Disrupts Key ASX200 Diplomacy as Albanese's Meeting Sc...

ASX-listed SUDA Pharmaceuticals Limited (SUD) has recently released its preliminary final report for the financial year ended 30^th June 2020 on the ASX. The Company observed several significant events during the financial year 2019-20, as listed below:

Finalising an agreement with Cann Pharma Australia
Entering into a fully funded feasibility study and option agreement with Laboratorios Ordesa, S.L.
Entering into a fully funded feasibility agreement with Sanofi
Entering into a License and Supply agreement with Mitsubishi Tanabe Pharma Korea
Announcing changes in senior management
Reporting impairment of ArTiMist®
Announcing capital raising activity to raise approximately $3.56 million
Attaining TGA approval for ZolpiMist^TM

SUDA closed the financial year with a consolidated loss of ~$9.9 million. As at 11:43 AM AEST, the Company’s stock is trading at $0.051.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.